GTHP

SEC source: 0001477932-25-006531 · form4.xml · nonDerivative · entry 2

Grujic Alan · CIK 0001980904 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F2 · kind: On August 21, 2025, Mr. Grujic converted 50 shares of Series E preferred stock into 200,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 conversion price.

F2 · price: On August 21, 2025, Mr. Grujic converted 50 shares of Series E preferred stock into 200,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 conversion price.

SEC source: 0001477932-25-006531 · form4.xml · nonDerivative · entry 1

Grujic Alan · CIK 0001980904 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,465,433

F1 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.2298.

F1 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.2298.

SEC source: 0001477932-25-006528 · form4.xml · nonDerivative · entry 3

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,296,828

F2 · kind: On August 21, 2025, Mr. Imhoff converted 300 shares of Series E preferred stock into 1,200,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 conversion price.

F2 · price: On August 21, 2025, Mr. Imhoff converted 300 shares of Series E preferred stock into 1,200,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 conversion price.

SEC source: 0001477932-25-006528 · form4.xml · nonDerivative · entry 2

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100

F2 · kind: On August 21, 2025, Mr. Imhoff converted 300 shares of Series E preferred stock into 1,200,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 conversion price.

F2 · price: On August 21, 2025, Mr. Imhoff converted 300 shares of Series E preferred stock into 1,200,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 conversion price.

SEC source: 0001477932-25-006528 · form4.xml · nonDerivative · entry 1

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,096,828

F1 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.2298.

F1 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.2298.

SEC source: 0001477932-25-006522 · form4.xml · nonDerivative · entry 5

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,924,180

F5 · kind: On August 21, 2025, Mr. Blumberg (WMB Pension Plan fbo Richard Blumberg) converted 233 shares of Series E preferred stock into 932,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 exercise price.

F5 · price: On August 21, 2025, Mr. Blumberg (WMB Pension Plan fbo Richard Blumberg) converted 233 shares of Series E preferred stock into 932,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 exercise price.

SEC source: 0001477932-25-006522 · form4.xml · nonDerivative · entry 4

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F5 · kind: On August 21, 2025, Mr. Blumberg (WMB Pension Plan fbo Richard Blumberg) converted 233 shares of Series E preferred stock into 932,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 exercise price.

F5 · price: On August 21, 2025, Mr. Blumberg (WMB Pension Plan fbo Richard Blumberg) converted 233 shares of Series E preferred stock into 932,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 exercise price.

SEC source: 0001477932-25-006522 · form4.xml · nonDerivative · entry 3

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,992,180

F4 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.2298.

F4 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.2298.

SEC source: 0001477932-25-004560 · form4.xml · derivative · entry 1

Grujic Alan · CIK 0001980904 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Common Stock · 110,000 shares

Expires 2035-06-02

F1 · derivative.exercise_date: One-fourth of the shares subject to the award vested on June 3, 2025; the remaining shares will vest monthly, starting on September 3, 2025, subject to the reporting person's continued service on each such date, until the award is fully vested on June 2, 2028.

SEC source: 0001477932-25-004559 · form4.xml · derivative · entry 1

Imhoff John E · CIK 0001348439 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Common Stock · 110,000 shares

Expires 2035-06-02

F1 · derivative.exercise_date: One-fourth of the shares subject to the award vested on June 3, 2025; the remaining shares will vest monthly, starting on September 3, 2025, subject to the reporting person's continued service on each such date, until the award is fully vested on June 2, 2028.

SEC source: 0001477932-25-004576 · form4.xml · derivative · entry 1

JAMES MICHAEL C · CIK 0001365831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Common Stock · 110,000 shares

Expires 2035-06-02

F1 · derivative.exercise_date: One-fourth of the shares subject to the award vested on June 3, 2025; the remaining shares will vest monthly, starting on September 3, 2025, subject to the reporting person's continued service on each such date, until the award is fully vested on June 2, 2028.

SEC source: 0001477932-25-006522 · form4.xml · derivative · entry 6

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Common Stock · 110,000 shares

Expires 2035-06-02

F3 · derivative.exercise_date: One-fourth of the shares are subject to the award vested on June 3, 2025; the remaining shares will vest monthly, starting on September 3, 2025, subject to the reporting person's continued service on each such date, until the award is fully vested on June 2, 2028.

SEC source: 0001477932-25-002818 · form4.xml · nonDerivative · entry 10

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,992,380

F6 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.0943.

F6 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.0943.

SEC source: 0001477932-25-004137 · form4a.xml · nonDerivative · entry 11

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,992,380

F7 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.0943.

F7 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.0943.

SEC source: 0001477932-25-006522 · form4.xml · nonDerivative · entry 2

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,911,059

F2 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series F-2 preferred stock, at a conversion price of $0.0943.

F2 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series F-2 preferred stock, at a conversion price of $0.0943.

SEC source: 0001477932-25-006522 · form4.xml · nonDerivative · entry 1

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,855,206

F1 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.0943.

F1 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.0943.

SEC source: 0001477932-25-002516 · form4.xml · derivative · entry 4

JAMES MICHAEL C · CIK 0001365831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 412,945

Underlying: Common Stock · 262,945 shares

Expires 2029-03-17

F2 · kind: In connection with the March Purchase Agreement, the Company entered into an exchange agreement with Mr. James, whereby Mr. James agreed to exchange a $25,000 note payable and accrued interest of $1,295 for 262,945 units as described above.

F2 · price: In connection with the March Purchase Agreement, the Company entered into an exchange agreement with Mr. James, whereby Mr. James agreed to exchange a $25,000 note payable and accrued interest of $1,295 for 262,945 units as described above.

SEC source: 0001477932-25-002516 · form4.xml · derivative · entry 3

JAMES MICHAEL C · CIK 0001365831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2029-03-17

F1 · kind: On March 18, 2025, the Company entered into a Securities Purchase Agreement (the "March Purchase Agreement") with Mr. James, pursuant to which the Company agreed to sell, for a total price of $15,000, an aggregate of 150,000 units, each unit consisting of one share of common stock and one warrant to purchase up to 150,000 shares of common stock (the "March Warrants"). The March Warrants were immediately exercisable upon issuance, expire four years following the issuance date and have an exercise price of $0.13 per share.

F1 · price: On March 18, 2025, the Company entered into a Securities Purchase Agreement (the "March Purchase Agreement") with Mr. James, pursuant to which the Company agreed to sell, for a total price of $15,000, an aggregate of 150,000 units, each unit consisting of one share of common stock and one warrant to purchase up to 150,000 shares of common stock (the "March Warrants"). The March Warrants were immediately exercisable upon issuance, expire four years following the issuance date and have an exercise price of $0.13 per share.

SEC source: 0001477932-25-002516 · form4.xml · nonDerivative · entry 2

JAMES MICHAEL C · CIK 0001365831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 525,717

F2 · kind: In connection with the March Purchase Agreement, the Company entered into an exchange agreement with Mr. James, whereby Mr. James agreed to exchange a $25,000 note payable and accrued interest of $1,295 for 262,945 units as described above.

SEC source: 0001477932-25-002516 · form4.xml · nonDerivative · entry 1

JAMES MICHAEL C · CIK 0001365831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 262,772

F1 · kind: On March 18, 2025, the Company entered into a Securities Purchase Agreement (the "March Purchase Agreement") with Mr. James, pursuant to which the Company agreed to sell, for a total price of $15,000, an aggregate of 150,000 units, each unit consisting of one share of common stock and one warrant to purchase up to 150,000 shares of common stock (the "March Warrants"). The March Warrants were immediately exercisable upon issuance, expire four years following the issuance date and have an exercise price of $0.13 per share.

SEC source: 0001477932-25-002818 · form4.xml · derivative · entry 12

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,263,069

Underlying: Common Stock · 263,069 shares

Expires 2029-03-17

F5 · kind: In connection with the March Purchase Agreement, the Company entered into an exchange agreement with Dr. Imhoff, whereby Dr. Imhoff agreed to exchange a $25,000 note payable and accrued interest of $1,307 for 263,069 units as described above.

F5 · price: In connection with the March Purchase Agreement, the Company entered into an exchange agreement with Dr. Imhoff, whereby Dr. Imhoff agreed to exchange a $25,000 note payable and accrued interest of $1,307 for 263,069 units as described above.

SEC source: 0001477932-25-002818 · form4.xml · derivative · entry 11

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common Stock · 1,000,000 shares

Expires 2029-03-17

F4 · kind: On March 18, 2025, the Company entered into a Securities Purchase Agreement (the "March Purchase Agreement") with Dr. Imhoff, pursuant to which the Company agreed to sell, for a total price of $100,000, 1,000,000 units, each unit consisting of one share of common stock and one warrant to purchase up to 1,000,000 shares of common stock (the "March Warrants"). The March Warrants were immediately exercisable upon issuance, expire four years following the issuance date and have an exercise price of $0.13 per share.

F4 · price: On March 18, 2025, the Company entered into a Securities Purchase Agreement (the "March Purchase Agreement") with Dr. Imhoff, pursuant to which the Company agreed to sell, for a total price of $100,000, 1,000,000 units, each unit consisting of one share of common stock and one warrant to purchase up to 1,000,000 shares of common stock (the "March Warrants"). The March Warrants were immediately exercisable upon issuance, expire four years following the issuance date and have an exercise price of $0.13 per share.

SEC source: 0001477932-25-002818 · form4.xml · nonDerivative · entry 9

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,986,015

F5 · kind: In connection with the March Purchase Agreement, the Company entered into an exchange agreement with Dr. Imhoff, whereby Dr. Imhoff agreed to exchange a $25,000 note payable and accrued interest of $1,307 for 263,069 units as described above.

SEC source: 0001477932-25-002818 · form4.xml · nonDerivative · entry 8

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,722,946

F4 · kind: On March 18, 2025, the Company entered into a Securities Purchase Agreement (the "March Purchase Agreement") with Dr. Imhoff, pursuant to which the Company agreed to sell, for a total price of $100,000, 1,000,000 units, each unit consisting of one share of common stock and one warrant to purchase up to 1,000,000 shares of common stock (the "March Warrants"). The March Warrants were immediately exercisable upon issuance, expire four years following the issuance date and have an exercise price of $0.13 per share.

SEC source: 0001477932-25-004137 · form4a.xml · derivative · entry 13

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,263,069

Underlying: Common Stock · 263,069 shares

Expires 2029-03-17

F6 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.0943.

F6 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.0943.

SEC source: 0001477932-25-004137 · form4a.xml · derivative · entry 12

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common Stock · 1,000,000 shares

Expires 2029-03-17

F5 · kind: In connection with the March Purchase Agreement, the Company entered into an exchange agreement with Dr. Imhoff, whereby Dr. Imhoff agreed to exchange a $25,000 note payable and accrued interest of $1,307 for 263,069 units as described above.

F5 · price: In connection with the March Purchase Agreement, the Company entered into an exchange agreement with Dr. Imhoff, whereby Dr. Imhoff agreed to exchange a $25,000 note payable and accrued interest of $1,307 for 263,069 units as described above.

SEC source: 0001477932-25-004137 · form4a.xml · nonDerivative · entry 10

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,986,015

F6 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.0943.

SEC source: 0001477932-25-004137 · form4a.xml · nonDerivative · entry 9

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,722,946

F5 · kind: In connection with the March Purchase Agreement, the Company entered into an exchange agreement with Dr. Imhoff, whereby Dr. Imhoff agreed to exchange a $25,000 note payable and accrued interest of $1,307 for 263,069 units as described above.

SEC source: 0001477932-25-004137 · form4a.xml · nonDerivative · entry 8

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400

F4 · kind: On March 13, 2025, for a purchase price of $30,000, Mr. Imhoff purchased 150 shares of Series E preferred stock from a third party. The shares have a conversion price of $0.25 and a stated value of $1,000.

F4 · price: On March 13, 2025, for a purchase price of $30,000, Mr. Imhoff purchased 150 shares of Series E preferred stock from a third party. The shares have a conversion price of $0.25 and a stated value of $1,000.

SEC source: 0001477932-25-002818 · form4.xml · nonDerivative · entry 7

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,722,946

F3 · kind: On March 7, 2025, for a purchase price of $112,934.50, Mr. Imhoff purchased 286 shares of Series C preferred stock from a third party. The shares had a conversion price of $0.1266, and on March 11, 2025 were converted to 2,258,690 common shares.

SEC source: 0001477932-25-002818 · form4.xml · nonDerivative · entry 6

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F3 · kind: On March 7, 2025, for a purchase price of $112,934.50, Mr. Imhoff purchased 286 shares of Series C preferred stock from a third party. The shares had a conversion price of $0.1266, and on March 11, 2025 were converted to 2,258,690 common shares.

F3 · price: On March 7, 2025, for a purchase price of $112,934.50, Mr. Imhoff purchased 286 shares of Series C preferred stock from a third party. The shares had a conversion price of $0.1266, and on March 11, 2025 were converted to 2,258,690 common shares.

SEC source: 0001477932-25-004137 · form4a.xml · nonDerivative · entry 7

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,722,946

SEC source: 0001477932-25-004137 · form4a.xml · nonDerivative · entry 6

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F3 · price: On March 7, 2025, for a purchase price of $112,934.50, Mr. Imhoff purchased 286 shares of Series C preferred stock from a third party. The shares had a conversion price of $0.1266, and on March 11, 2025 were converted to 2,258,690 common shares.

SEC source: 0001477932-25-002818 · form4.xml · nonDerivative · entry 5

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 286

F3 · kind: On March 7, 2025, for a purchase price of $112,934.50, Mr. Imhoff purchased 286 shares of Series C preferred stock from a third party. The shares had a conversion price of $0.1266, and on March 11, 2025 were converted to 2,258,690 common shares.

F3 · price: On March 7, 2025, for a purchase price of $112,934.50, Mr. Imhoff purchased 286 shares of Series C preferred stock from a third party. The shares had a conversion price of $0.1266, and on March 11, 2025 were converted to 2,258,690 common shares.

SEC source: 0001477932-25-004137 · form4a.xml · nonDerivative · entry 5

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 286

F3 · price: On March 7, 2025, for a purchase price of $112,934.50, Mr. Imhoff purchased 286 shares of Series C preferred stock from a third party. The shares had a conversion price of $0.1266, and on March 11, 2025 were converted to 2,258,690 common shares.

SEC source: 0001477932-25-002818 · form4.xml · nonDerivative · entry 4

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,464,256

F2 · kind: On March 6, 2025, Mr. Imhoff signed an exchange agreement to convert shares of Series C2 preferred stock at $0.50 conversion prices. For 2,400.75 Series C2 preferred shares, Mr. Imhoff received 4,801,500 common shares.

SEC source: 0001477932-25-002818 · form4.xml · nonDerivative · entry 3

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F2 · kind: On March 6, 2025, Mr. Imhoff signed an exchange agreement to convert shares of Series C2 preferred stock at $0.50 conversion prices. For 2,400.75 Series C2 preferred shares, Mr. Imhoff received 4,801,500 common shares.

F2 · price: On March 6, 2025, Mr. Imhoff signed an exchange agreement to convert shares of Series C2 preferred stock at $0.50 conversion prices. For 2,400.75 Series C2 preferred shares, Mr. Imhoff received 4,801,500 common shares.

SEC source: 0001477932-25-002818 · form4.xml · nonDerivative · entry 2

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,662,756

F1 · kind: On March 6, 2025, Mr. Imhoff converted 300 shares of Series D preferred stock into 900,000 shares of common stock. The Series D preferred stock had a stated value of $750 and $0.25 exercise price.

F1 · price: On March 6, 2025, Mr. Imhoff converted 300 shares of Series D preferred stock into 900,000 shares of common stock. The Series D preferred stock had a stated value of $750 and $0.25 exercise price.

SEC source: 0001477932-25-002818 · form4.xml · nonDerivative · entry 1

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: On March 6, 2025, Mr. Imhoff converted 300 shares of Series D preferred stock into 900,000 shares of common stock. The Series D preferred stock had a stated value of $750 and $0.25 exercise price.

F1 · price: On March 6, 2025, Mr. Imhoff converted 300 shares of Series D preferred stock into 900,000 shares of common stock. The Series D preferred stock had a stated value of $750 and $0.25 exercise price.

SEC source: 0001477932-25-004137 · form4a.xml · nonDerivative · entry 4

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,464,256

SEC source: 0001477932-25-004137 · form4a.xml · nonDerivative · entry 3

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F2 · price: On March 6, 2025, Mr. Imhoff signed an exchange agreement to convert shares of Series C2 preferred stock at $0.50 conversion prices. For 2,400.75 Series C2 preferred shares, Mr. Imhoff received 4,801,500 common shares.

SEC source: 0001477932-25-004137 · form4a.xml · nonDerivative · entry 2

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,662,756

F1 · price: On March 6, 2025, Mr. Imhoff converted 300 shares of Series D preferred stock into 900,000 shares of common stock. The Series D preferred stock had a stated value of $750 and $0.25 exercise price.

SEC source: 0001477932-25-004137 · form4a.xml · nonDerivative · entry 1

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · price: On March 6, 2025, Mr. Imhoff converted 300 shares of Series D preferred stock into 900,000 shares of common stock. The Series D preferred stock had a stated value of $750 and $0.25 exercise price.

SEC source: 0001477932-25-001072 · form4.xml · nonDerivative · entry 1

Imhoff John E · CIK 0001348439 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,762,756

F1 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series D preferred stock, at a conversion price of $0.1593.

F1 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series D preferred stock, at a conversion price of $0.1593.

SEC source: 0001477932-24-008256 · form4.xml · derivative · entry 2

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,615,385

Underlying: Common Stock · 1,615,385 shares

Expires 2028-12-17

F1 · kind: On December 18, 2024, the Company entered into a Securities Purchase Agreement with Mr. Imhoff pursuant to which, for an aggregate purchase price of $210,000, the Company issued 1,615,385 shares of its common stock and warrants to purchase an aggregate of 1,615,385 shares of common stock. The warrants were immediately exercisable upon issuance, expire four years following the issuance date and have an exercise price of $0.18 per share.

F1 · price: On December 18, 2024, the Company entered into a Securities Purchase Agreement with Mr. Imhoff pursuant to which, for an aggregate purchase price of $210,000, the Company issued 1,615,385 shares of its common stock and warrants to purchase an aggregate of 1,615,385 shares of common stock. The warrants were immediately exercisable upon issuance, expire four years following the issuance date and have an exercise price of $0.18 per share.

SEC source: 0001477932-24-008256 · form4.xml · nonDerivative · entry 1

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,727,444

F1 · price: On December 18, 2024, the Company entered into a Securities Purchase Agreement with Mr. Imhoff pursuant to which, for an aggregate purchase price of $210,000, the Company issued 1,615,385 shares of its common stock and warrants to purchase an aggregate of 1,615,385 shares of common stock. The warrants were immediately exercisable upon issuance, expire four years following the issuance date and have an exercise price of $0.18 per share.

SEC source: 0001477932-24-006671 · form4.xml · nonDerivative · entry 1

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,112,059

F1 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series D preferred stock, at a conversion price of $0.1556.

F1 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series D preferred stock, at a conversion price of $0.1556.

SEC source: 0001477932-24-006656 · form4.xml · nonDerivative · entry 1

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,689,725

F1 · kind: On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended on September 30, 2021 and November 11, 2022. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The common stock and warrants from the fourth tranche were issued on September 1, 2024 and October 14, 2024, respectively.

F1 · price: On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended on September 30, 2021 and November 11, 2022. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The common stock and warrants from the fourth tranche were issued on September 1, 2024 and October 14, 2024, respectively.

SEC source: 0001477932-24-006161 · form4.xml · derivative · entry 2

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,666,667

Underlying: Common Stock · 1,666,667 shares

Expires 2028-09-22

F1 · kind: On September 23, 2024, the Company entered into a Securities Purchase Agreement with Mr. Imhoff pursuant to which, for an aggregate purchase price of $150,000, the Company issued 1,666,667 shares of its common stock and warrants to purchase an aggregate of 1,666,667 shares of common stock. The warrants were immediately exercisable upon issuance, expire four years following the issuance date and have an exercise price of $0.12 per share.

F1 · price: On September 23, 2024, the Company entered into a Securities Purchase Agreement with Mr. Imhoff pursuant to which, for an aggregate purchase price of $150,000, the Company issued 1,666,667 shares of its common stock and warrants to purchase an aggregate of 1,666,667 shares of common stock. The warrants were immediately exercisable upon issuance, expire four years following the issuance date and have an exercise price of $0.12 per share.

SEC source: 0001477932-24-006161 · form4.xml · nonDerivative · entry 1

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,075,898

F1 · price: On September 23, 2024, the Company entered into a Securities Purchase Agreement with Mr. Imhoff pursuant to which, for an aggregate purchase price of $150,000, the Company issued 1,666,667 shares of its common stock and warrants to purchase an aggregate of 1,666,667 shares of common stock. The warrants were immediately exercisable upon issuance, expire four years following the issuance date and have an exercise price of $0.12 per share.